{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-002071","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.152165+00:00","generated_at":"2026-06-07T02:09:12.378555+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"OrthoPediatrics acquires Boston Orthotics & Prosthetics for $22M cash plus stock; secures $80M debt financing","bullets":["Acquired Boston O&P for $22M upfront cash plus ~83,000 restricted shares (~$2.5M) to employees.","Boston O&P has ~$25M annual revenue, 26 patient care clinics, and partnerships with major children's hospitals.","Acquisition expands OrthoPediatrics' Specialty Bracing division into $500M U.S. pediatric orthotic bracing market.","Closed $80M credit facility with MidCap Financial (term loan $30M, revolver $50M), replacing prior $50M line.","Combined entities have helped over 1 million children; targeting all 300 high-volume children's hospitals."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-002071","json":"https://secwatch.observer/filing/0001104659-24-002071.json","markdown":"https://secwatch.observer/filing/0001104659-24-002071.md","text":"https://secwatch.observer/filing/0001104659-24-002071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000110465924002071/0001104659-24-002071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000110465924002071/tm242260d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:09:12.378555+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2ac486a237b9ec07481207861aab201accbb5ee7","claim":"ORTHOPEDIATRICS CORP entered into Stock Purchase Agreement with Boston Brace International, Inc., the shareholders of Boston Brace (collectively, the Sellers) valued at $22 million in cash (effective 2024-01-05).","evidence_excerpt":"On January 5, 2024, OrthoPediatrics Corp. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Boston Brace International, Inc., a Massachusetts corporation (“Boston Brace”), the shareholders of Boston Brace (collectively, the “Sellers”), and the Sellers’ representative named therein (the “Sellers’ Representative”), pursuant to which the Company acquired all of the issued and outstanding shares of capital stock of Boston Brace from the Sellers.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000110465924002071/0001104659-24-002071-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Boston Brace International, Inc., the shareholders of Boston Brace (collectively, the Sellers)"},{"label":"Value","value":"$22 million in cash"},{"label":"Effective","value":"2024-01-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}